Bonraybio Co

Bonraybio Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Bonraybio Co (6955.TWO) as of Nov 2, 2026 is 1,037.56. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -141.02 — a change of -835.75% (higher).

EV/FCF

1,037.56

YoY

-835.75%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Bonraybio Co is 2022 1,037.56 . EV/FCF (Enterprise Value to Free Cash Flow) of Bonraybio Co was 2021 -141.02 . It decreases by -835.75% higher compared to the previous year.

The Bonraybio Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2020
-150.38 TWD
Jan 1, 2021
-141.02 TWD
Jan 1, 2022
1,037.56 TWD
The Bonraybio Co EV/FCF history
YEAREV/FCFYoY
1,037.56-835.75%
-141.02-6.22%
-150.38—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bonraybio Co Stock analysis

What does Bonraybio Co do? Bonraybio Co Ltd, a Taiwan-based biotechnology company headquartered in Taichung, develops and sells sperm testing systems. The company's products include sperm quality analysis testers, sperm testing reagents, sperm DNA debris testing reagent sets, sperm optimizers, quality control testing kits, sperm collection cups, and cleaning swabs. These products are marketed globally to customers seeking advanced reproductive health solutions. The firm generates revenue through direct sales of these specialized diagnostic tools and consumables to healthcare providers and fertility clinics worldwide. Bonraybio Co Ltd focuses on the biotechnology sector with a specialized product portfolio targeting reproductive health diagnostics. The company's offerings are designed for use in medical facilities and fertility centers, where they support sperm analysis and quality assessment processes. By providing comprehensive testing solutions, the company serves healthcare professionals requiring precise diagnostic tools for male fertility evaluation. The business model relies on selling high-precision diagnostic equipment and related consumables to international healthcare markets. Bonraybio's product range covers the entire sperm testing workflow from sample collection to analysis, creating a complete solution for fertility clinics. This integrated approach allows the company to maintain recurring revenue streams through the sale of reagents and disposable items alongside initial equipment purchases. Bonraybio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bonraybio Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Bonraybio Co is 1,037.56 in 2022.

EV/FCF (Enterprise Value to Free Cash Flow) of Bonraybio Co changed from -141.02 to 1,037.56, representing a -835.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Bonraybio Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Bonraybio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Bonraybio Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Bonraybio Co